Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer

2011 ◽  
Vol 227 (3) ◽  
pp. 1034-1041 ◽  
Author(s):  
Marta De Donato ◽  
Marisa Mariani ◽  
Lella Petrella ◽  
Enrica Martinelli ◽  
Gian Franco Zannoni ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Drug Resistance ◽  
Class Iii ◽  
Β Tubulin

Abstract 4055: Class III β-tubulin and the cytoskeletal gateway of drug resistance in ovarian cancer

2011 ◽  
Author(s):  
Marisa Mariani ◽  
Marta De Donato ◽  
Lella Petrella ◽  
Enrica Martinelli ◽  
Gabriella Ferrandina ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Drug Resistance ◽  
Class Iii ◽  
Β Tubulin

scholarly journals Class III β-Tubulin Overexpression Is a Marker of Poor Clinical Outcome in Advanced Ovarian Cancer Patients

2006 ◽  
Vol 12 (9) ◽  
pp. 2774-2779 ◽  
Author(s):  
Gabriella Ferrandina ◽  
Gian Franco Zannoni ◽  
Enrica Martinelli ◽  
Amelia Paglia ◽  
Valerio Gallotta ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Clinical Outcome ◽  
Cancer Patients ◽  
Advanced Ovarian Cancer ◽  
Class Iii ◽  
Poor Clinical Outcome ◽  
Β Tubulin

scholarly journals Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer

2018 ◽  
Vol 11 (2) ◽  
pp. 358-365 ◽  
Author(s):  
Enrica Martinelli ◽  
Andrea Fattorossi ◽  
Alessandra Battaglia ◽  
Marco Petrillo ◽  
Giuseppina Raspaglio ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Class Iii ◽  
Clinical Biomarkers ◽  
Tubulin Antibodies ◽  
Β Tubulin

Expression of ERCC1, p53, and Class III β-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer

2011 ◽  
Vol 21 (6) ◽  
pp. 1071-1077 ◽  
Author(s):  
Ingrid Vandenput ◽  
An Capoen ◽  
Lieve Coenegrachts ◽  
Godelieve Verbist ◽  
Philippe Moerman ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Class Iii ◽  
Β Tubulin
Sign in / Sign up

Export Citation Format

Share Document